Literature DB >> 23344730

Previous maternal infection protects offspring from enterovirus infection and prevents experimental diabetes development in mice.

P G Larsson1, T Lakshmikanth, E Svedin, C King, M Flodström-Tullberg.   

Abstract

AIMS/HYPOTHESIS: Enterovirus (e.g. Coxsackie B virus serotypes [CVBs]) infections may be associated with development of type 1 diabetes. Studies conducted in several European countries have, however, shown an inverse correlation between the incidence of type 1 diabetes and the prevalence of enterovirus infections. These findings could in part be explained by an extension of the poliovirus hypothesis, suggesting that the absence of maternally transferred antibodies protecting offspring from early infection increases the risk for diabetes development. Experimental evidence supporting this hypothesis in type 1 diabetes is, however, lacking. As maternally transferred protection from infection is a crucial component of the extended poliovirus hypothesis, we here tested the hypothesis that previously infected females transfer protection against infection and diabetes to offspring.
METHODS: The induction of CVB-specific maternal antibodies and transfer of protection from virus infection, replication and development of virus-induced diabetes to offspring was assessed using NOD and Socs1-transgenic NOD mice.
RESULTS: Infected mice produced neutralising antibodies to CVB. Offspring from infected females were positive for neutralising antibodies and were strongly protected from both infection and experimental diabetes. CONCLUSIONS/
INTERPRETATION: Our study shows that maternally transferred antibodies protect offspring from enterovirus infection and virus-induced diabetes. This suggests that the absence of maternally provided protection increases the risk for severe outcomes after an enterovirus infection in offspring. Moreover, our findings may have implications for the design of prospective studies aimed at investigating the possible role of enterovirus infections in the aetiology of human type 1 diabetes.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23344730     DOI: 10.1007/s00125-013-2834-z

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  40 in total

Review 1.  Coxsackievirus infection as an environmental factor in the etiology of type 1 diabetes.

Authors:  Martin J Richer; Marc S Horwitz
Journal:  Autoimmun Rev       Date:  2009-02-11       Impact factor: 9.754

2.  Hay fever, hygiene, and household size.

Authors:  D P Strachan
Journal:  BMJ       Date:  1989-11-18

Review 3.  The epidemiology of insulin dependent diabetes with particular reference to the relationship of virus infection to its etiology.

Authors:  D R Gamble
Journal:  Epidemiol Rev       Date:  1980       Impact factor: 6.222

4.  Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB Study.

Authors:  A G Ziegler; M Hummel; M Schenker; E Bonifacio
Journal:  Diabetes       Date:  1999-03       Impact factor: 9.461

5.  The first signs of beta-cell autoimmunity appear in infancy in genetically susceptible children from the general population: the Finnish Type 1 Diabetes Prediction and Prevention Study.

Authors:  T Kimpimäki; A Kupila; A M Hämäläinen; M Kukko; P Kulmala; K Savola; T Simell; P Keskinen; J Ilonen; O Simell; M Knip
Journal:  J Clin Endocrinol Metab       Date:  2001-10       Impact factor: 5.958

6.  Ablation of "tolerance" and induction of diabetes by virus infection in viral antigen transgenic mice.

Authors:  P S Ohashi; S Oehen; K Buerki; H Pircher; C T Ohashi; B Odermatt; B Malissen; R M Zinkernagel; H Hengartner
Journal:  Cell       Date:  1991-04-19       Impact factor: 41.582

7.  Diabetogenic potential of human pathogens uncovered in experimentally permissive beta-cells.

Authors:  Malin Flodström; Devin Tsai; Cody Fine; Amy Maday; Nora Sarvetnick
Journal:  Diabetes       Date:  2003-08       Impact factor: 9.461

8.  Target cell expression of suppressor of cytokine signaling-1 prevents diabetes in the NOD mouse.

Authors:  Malin Flodström-Tullberg; Deepak Yadav; Robert Hägerkvist; Devin Tsai; Patrick Secrest; Alexandr Stotland; Nora Sarvetnick
Journal:  Diabetes       Date:  2003-11       Impact factor: 9.461

9.  Transmission of immunoglobulin to foetal and neonatal mice.

Authors:  P Appleby; D Catty
Journal:  J Reprod Immunol       Date:  1983-07       Impact factor: 4.054

10.  Relationship between the incidence of type 1 diabetes and enterovirus infections in different European populations: results from the EPIVIR project.

Authors:  Hanna Viskari; Johnny Ludvigsson; Raivo Uibo; Lina Salur; Dalia Marciulionyte; Robert Hermann; Gyula Soltesz; Martin Füchtenbusch; Anette-G Ziegler; Anita Kondrashova; Anatolij Romanov; Mikael Knip; Heikki Hyöty
Journal:  J Med Virol       Date:  2004-04       Impact factor: 2.327

View more
  11 in total

Review 1.  Type 1 diabetes in mice and men: gene expression profiling to investigate disease pathogenesis.

Authors:  Linda Yip; C Garrison Fathman
Journal:  Immunol Res       Date:  2014-05       Impact factor: 2.829

Review 2.  Environmental risk factors for type 1 diabetes.

Authors:  Marian Rewers; Johnny Ludvigsson
Journal:  Lancet       Date:  2016-06-04       Impact factor: 79.321

3.  A preclinical study on the efficacy and safety of a new vaccine against Coxsackievirus B1 reveals no risk for accelerated diabetes development in mouse models.

Authors:  Pär G Larsson; Tadepally Lakshmikanth; Olli H Laitinen; Renata Utorova; Stella Jacobson; Maarit Oikarinen; Erna Domsgen; Minni R L Koivunen; Pascal Chaux; Nicolas Devard; Valerie Lecouturier; Jeffrey Almond; Mikael Knip; Heikki Hyöty; Malin Flodström-Tullberg
Journal:  Diabetologia       Date:  2014-11-05       Impact factor: 10.122

Review 4.  Type I diabetes mellitus: genetic factors and presumptive enteroviral etiology or protection.

Authors:  Jana Precechtelova; Maria Borsanyiova; Sona Sarmirova; Shubhada Bopegamage
Journal:  J Pathog       Date:  2014-12-10

Review 5.  The Role of Epigenetics in Type 1 Diabetes.

Authors:  Samuel T Jerram; Mary N Dang; R David Leslie
Journal:  Curr Diab Rep       Date:  2017-08-16       Impact factor: 4.810

6.  Coxsackievirus B4 vertical transmission in a murine model.

Authors:  Hela Jaïdane; Aymen Halouani; Habib Jmii; Firas Elmastour; Moncef Mokni; Mahjoub Aouni
Journal:  Virol J       Date:  2017-01-31       Impact factor: 4.099

7.  A hexavalent Coxsackievirus B vaccine is highly immunogenic and has a strong protective capacity in mice and nonhuman primates.

Authors:  V M Stone; M M Hankaniemi; O H Laitinen; A B Sioofy-Khojine; A Lin; I M Diaz Lozano; M A Mazur; V Marjomäki; K Loré; H Hyöty; V P Hytönen; M Flodström-Tullberg
Journal:  Sci Adv       Date:  2020-05-06       Impact factor: 14.136

Review 8.  Current understandings of the pathogenesis of type 1 diabetes: Genetics to environment.

Authors:  Adebola Matthew Giwa; Rizwan Ahmed; Zahra Omidian; Neha Majety; Kagan Ege Karakus; Sarah M Omer; Thomas Donner; Abdel Rahim A Hamad
Journal:  World J Diabetes       Date:  2020-01-15

9.  Enterovirus Neutralizing Antibodies, Monocyte Toll Like Receptors Expression and Interleukin Profiles Are Similar Between Non-affected and Affected Siblings From Long-Term Discordant Type 1 Diabetes Multiplex-Sib Families: The Importance of HLA Background.

Authors:  Carla Sanchez Bergamin; Elizabeth Pérez-Hurtado; Luanda Oliveira; Monica Gabbay; Valdecira Piveta; Célia Bittencourt; Denise Russo; Rita de Cássia Carmona; Maria Sato; Sergio A Dib
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-23       Impact factor: 5.555

10.  Vertical Transmission: A Vector-Independent Transmission Pathway of Babesia microti in the Natural Reservoir Host Peromyscus leucopus.

Authors:  Danielle M Tufts; Maria A Diuk-Wasser
Journal:  J Infect Dis       Date:  2021-05-28       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.